See the DrugPatentWatch profile for Buspar
What’s the difference between Buspar and its generic?
Buspar is the brand name for the drug buspirone, an anxiolytic that works by modulating serotonin receptors. The generic version uses the same active ingredient, buspirone, and is marketed under the name buspirone hydrochloride. Both brand and generic are approved by the FDA for the same indications, such as generalized anxiety disorder and certain anxiety disorders with agitation or panic symptoms. The only differences are in the manufacturer, labeling, and sometimes in the inactive ingredients used in the tablet matrix. The dosage strength (usually 5 mg or 10 mg tablets) and dosing schedule are identical.
[1]
Which companies sell generic buspirone?
Several generic manufacturers produce buspirone tablets. Common brands include Teva, Mylan, and Sandoz, among others. Each company typically offers the same 5 mg and 10 mg strengths, but the appearance of the tablet—color, shape, or imprint—may vary.
[1]
How do the prices of generic vs. brand Buspar compare?
Because the active ingredient is no longer under exclusive patent, generic buspirone is priced significantly lower than the brand‑name product. The generic often sells for a fraction of the brand cost—sometimes less than 30 % of the price of the original Buspar tablets. This lower cost is reflected in pharmacy pricing and insurance copays.
[1]
Do patients notice any differences in side‑effect profiles?
The safety profile of generic buspirone matches that of the brand. Common side effects include nausea, dizziness, headache, and dry mouth. Because the formulations are bioequivalent, no new or unexpected adverse reactions are expected when switching from brand to generic.
[1]
When are the patents on Buspar expected to expire?
The primary patents that covered the original Buspar formulation have long since expired. This expiration opened the market to generic competition, allowing manufacturers to produce lower‑cost versions without infringing. The exact expiration dates vary by specific patent (e.g., formulation, dosage form), but all major patents protecting buspirone as a drug compound have lapsed.
[1]
Can a patient switch from brand to generic safely?
Yes. Because generic buspirone meets FDA bioequivalence standards, switching from the brand name to a generic is considered safe and effective. Patients should consult their prescriber or pharmacist to confirm the specific generic product’s label and dosage.
---
Sources
[1] https://www.drugpatentwatch.com/Buspar